Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines
<h3>Objective</h3><p dir="ltr">The aim of the study was to assess the quality of the recently published European clinical practice guidelines for the management of dyslipidaemias, utilizing the refined Appraisal of Guidelines for Research & Evaluation tool.</p>&...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513554030264320 |
|---|---|
| author | Eman N Alhmoud (20352048) |
| author2 | Raja Barazi (13955772) Amr Fahmi (20352051) Abdullah Abdu (20352054) Alya Higazy (18112264) Maguy ElHajj (20352057) |
| author2_role | author author author author author |
| author_facet | Eman N Alhmoud (20352048) Raja Barazi (13955772) Amr Fahmi (20352051) Abdullah Abdu (20352054) Alya Higazy (18112264) Maguy ElHajj (20352057) |
| author_role | author |
| dc.creator.none.fl_str_mv | Eman N Alhmoud (20352048) Raja Barazi (13955772) Amr Fahmi (20352051) Abdullah Abdu (20352054) Alya Higazy (18112264) Maguy ElHajj (20352057) |
| dc.date.none.fl_str_mv | 2020-07-12T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1111/jphs.12371 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Critical_Appraisal_of_the_Clinical_Practice_Guidelines_for_the_Management_of_Dyslipidaemias_Lipid_Modification_to_Reduce_Cardiovascular_Risk_European_Society_of_Cardiology_ESC_and_European_Atherosclerosis_Society_ESC_EAS_2019_Guidelines/27924978 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Health sciences Public health clinical practice guidelines dyslipidaemias management cardiovascular risk EAS ESC |
| dc.title.none.fl_str_mv | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Objective</h3><p dir="ltr">The aim of the study was to assess the quality of the recently published European clinical practice guidelines for the management of dyslipidaemias, utilizing the refined Appraisal of Guidelines for Research & Evaluation tool.</p><h3>Method</h3><p dir="ltr">The 2019 European Society of Cardiology and European Atherosclerosis Society Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk was appraised and scored for methodological rigour and transparency by 5 independent appraisers using a validated tool.</p><h3>Key findings</h3><p dir="ltr">The guideline scored highest in the domains that evaluated editorial independence (100%) and clarity of presentation (98.6%) and lowest in the domains that addressed stakeholder involvement (55.56%) and rigour of development (63%). Overall the quality of the guideline was high, and all reviewers recommended its use in practice.</p><h3>Conclusion</h3><p dir="ltr">The guideline’s overall quality was judged to be high, and all appraisers recommended its use in practice without modifications.</p><h2>Other Information</h2><p dir="ltr">Published in: Journal of Pharmaceutical Health Services Research<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1111/jphs.12371" target="_blank">https://dx.doi.org/10.1111/jphs.12371</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_3557d482b2ac15326ef1e6cd26eb7c82 |
| identifier_str_mv | 10.1111/jphs.12371 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/27924978 |
| publishDate | 2020 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 GuidelinesEman N Alhmoud (20352048)Raja Barazi (13955772)Amr Fahmi (20352051)Abdullah Abdu (20352054)Alya Higazy (18112264)Maguy ElHajj (20352057)Biomedical and clinical sciencesCardiovascular medicine and haematologyHealth sciencesPublic healthclinical practice guidelinesdyslipidaemiasmanagementcardiovascular riskEASESC<h3>Objective</h3><p dir="ltr">The aim of the study was to assess the quality of the recently published European clinical practice guidelines for the management of dyslipidaemias, utilizing the refined Appraisal of Guidelines for Research & Evaluation tool.</p><h3>Method</h3><p dir="ltr">The 2019 European Society of Cardiology and European Atherosclerosis Society Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk was appraised and scored for methodological rigour and transparency by 5 independent appraisers using a validated tool.</p><h3>Key findings</h3><p dir="ltr">The guideline scored highest in the domains that evaluated editorial independence (100%) and clarity of presentation (98.6%) and lowest in the domains that addressed stakeholder involvement (55.56%) and rigour of development (63%). Overall the quality of the guideline was high, and all reviewers recommended its use in practice.</p><h3>Conclusion</h3><p dir="ltr">The guideline’s overall quality was judged to be high, and all appraisers recommended its use in practice without modifications.</p><h2>Other Information</h2><p dir="ltr">Published in: Journal of Pharmaceutical Health Services Research<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1111/jphs.12371" target="_blank">https://dx.doi.org/10.1111/jphs.12371</a></p>2020-07-12T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1111/jphs.12371https://figshare.com/articles/journal_contribution/Critical_Appraisal_of_the_Clinical_Practice_Guidelines_for_the_Management_of_Dyslipidaemias_Lipid_Modification_to_Reduce_Cardiovascular_Risk_European_Society_of_Cardiology_ESC_and_European_Atherosclerosis_Society_ESC_EAS_2019_Guidelines/27924978CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/279249782020-07-12T03:00:00Z |
| spellingShingle | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines Eman N Alhmoud (20352048) Biomedical and clinical sciences Cardiovascular medicine and haematology Health sciences Public health clinical practice guidelines dyslipidaemias management cardiovascular risk EAS ESC |
| status_str | publishedVersion |
| title | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines |
| title_full | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines |
| title_fullStr | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines |
| title_full_unstemmed | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines |
| title_short | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines |
| title_sort | Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Health sciences Public health clinical practice guidelines dyslipidaemias management cardiovascular risk EAS ESC |